Cathay Drug

What Cathay Drug does

Cathay Drug, formally The Cathay Drug Company, Inc., is a Filipino pharmaceutical marketing and distribution organization founded in 1952 and held by the Yao Shiong Shio family. Headquartered in Makati City, the company operates exclusively within the Philippines and distributes pharmaceutical products acquired through licensing and supply agreements with national and international principals including Sandoz, Swisspharma, Taiwan Biotech, URGO, Aldo-Union, Ajanta Pharma, Daewoong, Ethypharm, Biopharm, and Ezambon. The company employs a combined headcount of roughly 566 across a 310+ field force, 163+ administrative staff, 15+ medical affairs team, and 78+ production/manufacturing staff, and was ranked No. 8 in the Philippine Pharmaceutical Industry Audit (Ethical segment) and No. 2 among national pharmaceutical companies in that segment by IMS OR as of June 2015.

The commercial model is sales-led: a field force of 310+ Territory Managers directly markets and distributes pharmaceutical products to healthcare professionals and institutions across the country, supplemented by participation in major medical congresses (Asia Pacific Congress of Pediatrics, PSMID, Philippine Pediatric Society, POGS), postgraduate presentations, and HCP engagement programs. Revenue is generated through sale of licensed pharmaceutical products under one-time license arrangements with international principals; specific pricing is not publicly disclosed but is positioned to be affordable for low-income populations.

Beyond core distribution, Cathay Drug offers telehealth services for remote and mobility-constrained patients, runs community health programs, and partners with YWAM Ships Philippines to deliver medicines and healthcare resources to underserved island communities. The company has no disclosed funding, no public listing, no parent company, and no subsidiaries; operations remain concentrated in a single geography (Philippines) with no global footprint claim.

Name

Cathay Drug

Legal name

The Cathay Drug Company, Inc.

Website

https://cathaydrug.com

Company type

Private

Founded year

1952

Operating status

Operating

Headcount range

251–500 employees

Short description

Cathay Drug is a Filipino pharmaceutical marketing and distribution company, family-owned since 1952, that licenses products from international pharma principals and distributes them across the Philippines via a 310+ field force targeting healthcare professionals, patients, and underserved island communities.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industry

Pain Management, Anesthesia & Critical Care Drugs (HLAMAEAF)

Keywords

• Pharmaceutical distribution
• Pharmaceutical marketing
• Healthcare product distribution
• Ethical pharmaceuticals
• Pharmaceutical licensing

Headquarters

HQ city

Makati

HQ country

Philippines

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Marketing or Sales, Operations, Supply Chain, Technology or R&D

Revenue model

1. Pharmaceutical Product Distribution: The company generates revenue through marketing and distribution of pharmaceutical products acquired through licensing and supply agreements with national and international pharmaceutical companies. Revenue is derived from the sale of licensed pharmaceutical products within the Philippines.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Cathay Drug Company, Inc. is a Filipino pharmaceutical organization established in 1952 that markets and distributes human and animal healthcare products exclusively within the Philippines. The company acquires pharmaceutical products through licensing and supply agreements with national and international pharmaceutical companies and distributes them through a 310+ field force of representatives to healthcare institutions and professionals nationwide. Complementary services include affordable pricing strategies, telehealth services, community health programs, and patient-centered care initiatives.

Product overview

Cathay Drug is a pharmaceutical marketing and distribution company operating in the Philippines. The company acquires pharmaceutical products through licensing and supply agreements with international companies and markets them to healthcare providers and patients. Their product portfolio includes pharmaceutical drugs across various therapeutic categories, though specific product names are not detailed in the available source material. The company also provides supporting services including affordable pricing strategies, telehealth services, community health programs, patient-centered care initiatives, and partnerships for healthcare access in underserved communities.

Differentiator

Problem solved

Functional benefit

Products and services

• Licensed Pharmaceutical Products (Human and Animal Healthcare) Human and animal healthcare pharmaceutical products acquired through licensing and supply agreements with international pharmaceutical companies, marketed and distributed to healthcare professionals and institutions across the Philippines via a 310+ field force.
• Telehealth Services

Quantifiable outcome

• Ranked No. 2 among national pharmaceutical companies (ethical segment)
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Eleven partnerships are on record, tiered core and minor.

• SandozcoreChannel Partner/ Reseller/ DistributorSandoz is a global pharmaceutical company that provides generic pharmaceuticals. Cathay Drug distributes Sandoz products in the Philippines through supply and licensing agreements.
• SwisspharmacoreChannel Partner/ Reseller/ DistributorSwisspharma is a pharmaceutical company whose products are distributed by Cathay Drug in the Philippines.
• Taiwan BiotechcoreChannel Partner/ Reseller/ DistributorTaiwan Biotech is a biotechnology company whose products are distributed by Cathay Drug in the Philippines.
• URGOcoreChannel Partner/ Reseller/ DistributorURGO is a pharmaceutical company specializing in wound care and other medical products, distributed by Cathay Drug in the Philippines.
• Aldo-UnioncoreChannel Partner/ Reseller/ DistributorAldo-Union is a pharmaceutical company whose products are distributed by Cathay Drug in the Philippines.
• Ajanta PharmacoreChannel Partner/ Reseller/ DistributorAjanta Pharma is an Indian pharmaceutical company whose products are distributed by Cathay Drug in the Philippines through licensing agreements.
• BiopharmcoreChannel Partner/ Reseller/ DistributorBiopharm is a pharmaceutical company whose products are distributed by Cathay Drug in the Philippines.
• DaewoongcoreChannel Partner/ Reseller/ DistributorDaewoong is a South Korean pharmaceutical company whose products are distributed by Cathay Drug in the Philippines.
• EthypharmcoreChannel Partner/ Reseller/ DistributorEthypharm is a pharmaceutical company specializing in complex drugs and combination products, distributed by Cathay Drug in the Philippines.
• EzamboncoreChannel Partner/ Reseller/ DistributorEzambon is a pharmaceutical company whose products are distributed by Cathay Drug in the Philippines.
• YWAM Ships PhilippinesminorStrategic or Co-development PartnerYWAM Ships Philippines partners with Cathay Drug to provide medicines and healthcare resources to underserved island communities, improving access to basic health services. This is a community-focused partnership addressing healthcare accessibility in remote Philippine islands.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Others

• Ajanta Pharma: Ajanta Pharma is an Indian generic manufacturer whose products are distributed in the Philippines through Cathay Drug. It is comparable as both supplier/partner and a potential direct entrant in the Philippine market.
• Sandoz (Novartis): Sandoz is one of Cathay Drug's core licensing partners for generic pharmaceuticals in the Philippines. As a global generics leader, Sandoz is thematically related as both supplier and competitive threat, given Sandoz's ability to switch distributors or go direct.
• Daewoong Pharmaceutical: Daewoong is a South Korean pharmaceutical manufacturer whose products are distributed in the Philippines via Cathay Drug. Comparable as a current licensing partner whose decision to retain or switch distribution channels directly affects Cathay's portfolio.

Direct peers

• Metro Drug: Metro Drug is a Filipino pharmaceutical distributor with a national field force marketing and distributing ethical products. It competes head-to-head with Cathay Drug across therapeutic categories and HCP segments in the Philippines.
• RiteMed Philippines: RiteMed is a Filipino pharmaceutical company focused on affordable generic medicines distributed nationwide. It directly competes with Cathay Drug in the ethical/generic segment of the Philippine pharmaceutical market, leveraging similar affordability positioning and broad HCP reach.
• Zuellig Pharma: Zuellig Pharma is the largest pharmaceutical distributor in the Philippines and across Southeast Asia. It is the most direct competitor to Cathay Drug as both operate field-force-driven pharma distribution models supplying licensed products from multinational manufacturers to HCPs and institutions across the Philippines.

Broad incumbents

• Novartis Philippines: Novartis is the parent of Sandoz and operates branded pharma directly in the Philippines. Comparable as a multinational ethical pharma operator whose products overlap with Cathay's distribution portfolio.
• United Laboratories (Unilab): Unilab is the largest Filipino-owned pharmaceutical company, with manufacturing and broad distribution of branded and generic ethical products. It competes with Cathay in the same ethical segment but operates its own manufacturing and a much larger branded portfolio.
• Sanofi Philippines: Sanofi is a multinational pharmaceutical company marketing branded ethical products through its Philippines subsidiary. Comparable as a multinational competitor with direct operations in the same ethical segment Cathay serves.
• Pfizer Philippines: Pfizer is a multinational pharmaceutical company with direct presence in the Philippines marketing branded ethical products. It competes for the same HCP prescriptions and could potentially bypass distributors by deepening its own operations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cathay Drug